raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:447757

Autosomal dominant spastic paraplegia type 9B

Synonyms: AD-SPG9B

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adolescent, Adult, Infancy
Status
active

A rare predominantly pure hereditary spastic paraplegia characterized by juvenile or adult onset of slowly progressive spastic paraparesis, gait disturbances, and increased tendon reflexes. Additional variable manifestations include pes cavus, dysarthria, sensory impairment, and urinary symptoms. Cognition is normal.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal dominant spastic paraplegia type 9BAD-SPG9B
frParaplégie spastique autosomique dominante type 9B= en
deSpastische Paraplegie, autosomal-dominante, Typ 9B= en
esParaplejía espástica autosómica dominante tipo 9B= en
itParaplegia spastica autosomica dominante tipo 9B= en
nlAutosomaal dominante spastische paraplegie type 9B= en
ptParaplegia espástica autossómica dominante tipo 9B= en
plAutosomalna dominująca złożona paraplegia spastyczna typu 9B= en
csAutozomálně dominantní spastická paraplegie, typ 9B= en
ukАутосомно-домінантна спастична параплегія, тип 9B= en
zh常染色体显性痉挛性截瘫9B型= en
trOtozomal dominant spastik parapleji tip 9B= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10G11.4NTBTattributedvalidated
ICD-118B44.00NTBTattributedvalidated
MONDO0018644Evalidated
MONDO18644Evalidated
UMLSC5568979Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ALDH18A1Disease-causing germline mutation(s) (loss of function) inAssessedHGNC:9722ENSG0000005957313825010q24.1aldehyde dehydrogenase 18 family member A126026163[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families3 familiesWorldwideFamily(ies)Validated26026163[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_26026163[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

21 annotations · validated 2019-02-01
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0003487Babinski sign
HP:0007083Hyperactive patellar reflex
HP:0007350Hyperreflexia in upper limbs
HP:0002505Loss of ambulation
HP:0007178Motor polyneuropathy
HP:0001761Pes cavus
HP:0002174Postural tremor
HP:0007240Progressive gait ataxia
HP:0002344Progressive neurologic deterioration
HP:0002464Spastic dysarthria
HP:0002064Spastic gait
HP:0002493Upper motor neuron dysfunction
Occasional (29-5%)
HP:0003438Absent Achilles reflex
HP:0006827Atrophy of the spinal cord
HP:0000726Dementia
HP:0000519Developmental cataract
HP:0002987Elbow flexion contracture
HP:0004373Focal dystonia
HP:0002020Gastroesophageal reflux
HP:0001252Hypotonia
HP:0003477Peripheral axonal neuropathy

Annotation source: 26026163[PMID]

7

Sources for this card